---
created: 2025-04-13
updated: 2025-04-13T10:53
id: dqzuN{t)JY
specialty: ortho
specialty_id: 85
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/firstaid::11-musculoskeletal-skin-connective-tissue::04-pharm::06-leflunomide
  - "source/ak-step1-v11:": 
  - source/ome-banner::basic-science::02-metabolism
  - "source/ak-step1-v11:": 
  - theme/physeo::05-biochem::05-metabolism::18-purines-&-pyrimidines
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::09-musculoskeletal::05-leflunomide
  - "source/ak-step1-v11:": 
  - theme/pixorize::02-biochem::02-pathways::12-de-novo-pyrimidine-synthesis
  - "source/ak-step1-v11:": 
  - theme/pixorize::03-pharm::12-msk::leflunomide
  - "source/ak-step1-v11:": 
  - theme/sketchybiochem::03-molecular-biology::01-dna::05-purine-(de-novo)-pyrimidine-synthesis
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::miscellaneous-pharm
  - source/ak-step1-v11::^other::^expn
  - source/ak-step1-v11::^other::^highyield::3-highyield-temporary
  - source/ak-step1-v11::^systems::musculoskeletal::pharmacology"
type: flashcard
---

# Question
Leflunomide is an antimetabolite that reversibly inhibits **dihydroorotate dehydrogenase** preventing **pyrimidine** synthesis

---

# Answer
this plays a key role in the denovo synthesis of rUMP, which is especially important in rapidly dividing cells (eg, T cells) to make CMP and TMP down the line